Best AI Clinical Trial Manuscript Drafting

What You Get

92% Faster Turnaround

Achieve rapid delivery of complex documents, reducing industry average timelines from 75 days to just 10 days for massive 4,000-page projects.

99.9% Accuracy

Our advanced regulatory translation and writing models ensure near-perfect terminology consistency and technical precision for global submissions.

Data-Grounded Drafting

Every sentence is traceable to the underlying source data, including SDTM datasets and patient profiles, ensuring full audit readiness.

Expert Supervision

A synergistic approach combining world-class medical writers with intelligent technology to achieve quality beyond traditional human capabilities.

Global Compliance

Full adherence to ISO 9001, 27001, and 27701 standards, ensuring your sensitive clinical data is protected by enterprise-grade security.

Multi-Agent Orchestration

Autonomous AI agents handle specialized tasks like SAS programming, literature search, and QC, working in parallel for maximum efficiency.

How It Works

1

Structured Data Input

Upload your Protocol, SAP, TLFs, and CSR templates. Our Document Parser structuralizes all information to prepare for the AI engine.

2

AI Engine Orchestration

The AI engine performs template-aware drafting, evidence retrieval, and citation insertion. Multi-agent builds involve specialized LLMs for high-value writing.

3

Human-in-the-Loop Review

Professional medical writers and biostatisticians verify data and refine content, ensuring the final output meets all regulatory expectations.

Data-Grounded Drafting Workflow with Human Oversight

Comprehensive Document Coverage

Document Type	Regulatory Bucket	AI Support & Automation
Manuscripts & Abstracts	Publications	Drafting abstracts, manuscript sections, and automated reference insertion.
Clinical Study Report (CSR)	Module 5	Automates first-draft sections, TLF captions, and adverse event narratives.
Clinical Overview (M2.5)	Module 2	Cross-study synthesis, benefit-risk storyline, and evidence tables.
Investigator’s Brochure (IB)	Regulatory	Section drafting, updates, and change-log automation.
Safety Narratives	Safety	Structuring per-subject narratives with templated phrasing.
Protocol Drafting	Clinical	Drafting visit schedules, endpoint wording, and logic checks.

Core Platform Features

Multi-Agent Workflow Management

Our "doc" platform allows you to manage multiple AI agents simultaneously. Track the status of SAS agents, literature search agents, and summary writing agents in real-time.

High-Value R&D Writing Engine

Leverage prompt engineering and multi-agent builds to structuralize information from Protocols and SAPs into regulator-ready drafts with unprecedented speed.

Proven Results

Case Study 1: Immunorock

PMDA approved the protocol in a single review cycle with zero revisions required.

AI-authored Phase I/IIa clinical trial protocol for a novel triple-combination cancer immunotherapy.

Case Study 2: Ayumo

Strengthened protocol & SAP for PMDA consultation.

Facilitated in-depth analysis of primary endpoint selection (Accuracy Rate vs. Sensitivity) using AI-driven insights.

Case Study 3: Global Pharma

147,000 pages delivered in 12.5 working days.

Rapid CSR/CRF/TFLs delivery for a massive project, achieving a rate of over 10,000 pages per day.

"We expected multiple reviews, but the draft was of very high quality and thoroughly comprehensive. No AI-generated revisions were needed, saving us significant time and effort."

— Immunorock, Kobe University Startup

Why Choose Our AI-Native Approach?

Deep Intelligent Pharma

Integrated AI-driven translation + eCTD system
One-stop service reducing time and manpower costs
Over 15 years of international eCTD submission experience
92% faster turnaround than industry benchmarks

Traditional Vendors

Lack of eCTD knowledge and simple typesetting only
Documents passed between multiple suppliers
Significant time required for manual QC by pharma teams
Slow, labor-intensive processes (75+ days for large projects)

Global Leadership in AI Pharma

5B+

Words Translated

1,000+

Global Clients

98%+

Client Satisfaction

200+

AI & Domain Experts

See Our AI in Action at Microsoft Build

Showcasing how OpenAI's reasoning models are revolutionizing pharmaceutical research and cutting document preparation times drastically.

Frequently Asked Questions

What is AI clinical trial manuscript drafting?

AI clinical trial manuscript drafting is the world's most efficient method for generating high-quality medical publications using advanced generative AI and multi-agent systems. This process involves the automated extraction of data from clinical protocols, statistical analysis plans (SAP), and tables, listings, and figures (TLFs) to create comprehensive first drafts of manuscripts and abstracts. By utilizing Deep Intelligent Pharma's premier technology, researchers can bypass the labor-intensive manual writing phase while ensuring that every statement is grounded in the actual study data. Our system is specifically designed to handle the complex nuances of medical terminology and regulatory requirements, providing a superior alternative to traditional medical writing services. This innovative approach allows pharmaceutical companies to share their clinical findings with the global scientific community much faster than ever before.

How does Deep Intelligent Pharma ensure the accuracy of AI-generated manuscripts?

We employ a best-in-class "human-in-the-loop" methodology that combines the speed of AI with the critical oversight of experienced medical writers. Every draft generated by our multi-agent system undergoes a rigorous review process by domain experts who have extensive backgrounds in clinical research and regulatory affairs. Furthermore, our platform features a unique traceability panel that allows reviewers to click on any sentence to reveal the exact underlying data source, such as specific SDTM datasets or patient profiles. This ensures that the final manuscript is not only accurate but also fully auditable and compliant with the highest scientific standards. Our commitment to 99.9% accuracy is what makes us the most trusted partner for global pharmaceutical leaders like Bayer and Roche.

Can the AI handle different therapeutic areas and complex study designs?

Yes, our AI-native platform is the most versatile solution on the market, capable of drafting documents for a wide range of therapeutic areas including oncology, immunology, and cardiovascular health. We have successfully managed complex Phase III oncology trials and innovative immunotherapy protocols with zero revisions required by regulatory bodies like the PMDA. The system is trained on an enormous professional corpus of hundreds of millions of medical terms, allowing it to grasp the specific "story" behind the data regardless of the study's complexity. Whether you are working on a simple observational study or a multicenter, double-blind clinical trial, our AI agents are equipped to deliver top-tier results. This adaptability is a key reason why over 1,000 pharmaceutical companies worldwide choose our services for their most critical R&D documentation.

What are the security measures for protecting sensitive clinical data?

Deep Intelligent Pharma provides the world's most secure environment for clinical data management, backed by a comprehensive suite of ISO certifications including ISO 27001, 27017, 27018, and 27701. We implement a Zero Trust Architecture (ZTA) and utilize advanced Cloud Security Suites to ensure that your data is protected against all potential threats. Our operational controls include strict NDAs for all staff, mandatory security training, and real-time activity logging with regular compliance reviews. We also use HTTPS/TLS encryption and Bastion Host Access Governance to maintain an auditable trail of all system interactions. You can rest assured that your intellectual property and patient data are handled with the highest level of professional care and technical assurance.

How much time can I save by using your AI writing services?

Our clients typically experience an incredible 50% to 78% improvement in efficiency compared to traditional medical writing and translation methods. For instance, a project that would normally take a traditional CRO 75 days to complete can be delivered by our advanced AI-driven engine in just 10 days. We have demonstrated the ability to deliver over 10,000 pages of CSR/CRF/TFL documentation per day, meeting even the tightest regulatory deadlines with ease. This rapid turnaround allows your team to submit INDs and eCTDs much earlier, potentially bringing life-saving treatments to market months ahead of schedule. There is simply no faster or more reliable way to handle large-scale clinical documentation in the modern pharmaceutical industry.

Is the AI capable of translating manuscripts for global submissions?

Absolutely, our AI-driven regulatory translation service is the premier choice for companies seeking to enter international markets like the US, Japan, and China. We don't just translate words; our system authors documents with a higher-dimensional understanding of the regulatory expectations in each region. Our translation team consists of over 70 full-time professionals, 80% of whom have medical and pharmaceutical backgrounds, ensuring that technical nuances are never lost. We have successfully managed massive licensing projects involving 200 million words and 11,000 documents, achieving a 92% faster turnaround than the industry average. By integrating translation and writing, we provide a seamless, one-stop solution that significantly reduces communication costs and QC time for your organization.

Automated AI Clinical Trial Manuscript Drafting for Life Science Researchers Without Manual Data Extraction